Skip to main content
. Author manuscript; available in PMC: 2022 Jul 5.
Published in final edited form as: Am J Kidney Dis. 2021 Mar 31;78(1):38–47. doi: 10.1053/j.ajkd.2020.10.015

Table 2.

Adjusted urine electrolytes during the control and alkali periods by CKD status.

Urine diet biomarker Non-CKD (n=6) CKD (n=8)

Control period Alkali period Control period Alkali period
Urea nitrogen, g/d 9.3 ± 2.0 9.5 ± 1.9 8.5 ± 1.6 8.3 ± 1.8
Potassium, mmol/d 63.0 ± 12.0 59.0 ± 12.9 52.7 ± 7.1 52.5 ± 4.2
Sodium, mmol/d 105.3 ± 21.1 94.0 ± 32.8 107.7 ± 21.1 101.1 ± 10.5
Magnesium, mg/d 84.2 ± 15.5 81.5 ± 15.3 63.3 ± 22.3 61.8 ± 22.1
Calcium, mmol/d 149.7 ± 65.9a 143.6 ± 80.7b 53.5 ± 40.7a 48.9 ± 38.9b
Sulfate, mmol/d 34.1 ± 10.6 34.3 ± 10.5 30.0 ± 10.1 30.0 ± 9.3
Phosphorus, g/d 0.6 ± 0.2 0.6 ± 0.2 0.5 ± 0.1 0.5 ± 0.1

Data expressed as means ± standard deviations. All participants completed two consecutive 24-hour urine collections at the end of the alkali and control periods except one participant in the non-CKD group who completed one 24-hour urine collection at the end of the control period. Urine electrolytes are calibrated by regression to a constant mean urine creatinine concentration in each individual over the study period. P-values for between group difference during the control and alkali periods were

a

<0.01 and

b

0.01, respectively.